Literature DB >> 18773501

Homologous and heterologous recombination between adenovirus vector DNA and chromosomal DNA.

Sam Laurel Stephen1, Vijayshankar Ganesh Sivanandam, Stefan Kochanek.   

Abstract

BACKGROUND: Adenovirus vector DNA is perceived to remain as episome following gene transfer. We quantitatively and qualitatively analysed recombination between high capacity adenoviral vector (HC-AdV) and chromosomal DNA following gene transfer in vitro.
METHODS: We studied homologous and heterologous recombination with a single HC-AdV carrying (i) a large genomic HPRT fragment with the HPRT CHICAGO mutation causing translational stop upon homologous recombination with the HPRT locus and (ii) a selection marker to allow for clonal selection in the event of heterologous recombination. We analysed the sequences at the junctions between vector and chromosomal DNA.
RESULTS: In primary cells and in cell lines, the frequency of homologous recombination ranged from 2 x 10(-5) to 1.6 x 10(-6). Heterologous recombination occurred at rates between 5.5 x 10(-3) and 1.1 x 10(-4). HC-AdV DNA integrated via the termini mostly as intact molecules. Analysis of the junction sequences indicated vector integration in a relatively random manner without an obvious preference for particular chromosomal regions, but with a preference for integration into genes. Integration into protooncogenes or tumor suppressor genes was not observed. Patchy homologies between vector termini and chromosomal DNA were found at the site of integration. Although the majority of integrations had occurred without causing mutations in the chromosomal DNA, cases of nucleotide substitutions and insertions were observed. In several cases, deletions of even relative large chromosomal regions were likely.
CONCLUSIONS: These results extend previous information on the integration patterns of adenovirus vector DNA and contribute to a risk-benefit assessment of adenovirus-mediated gene transfer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18773501     DOI: 10.1002/jgm.1246

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  17 in total

Review 1.  Viral vectors for gene delivery to the central nervous system.

Authors:  Thomas B Lentz; Steven J Gray; R Jude Samulski
Journal:  Neurobiol Dis       Date:  2011-10-07       Impact factor: 5.996

Review 2.  Hepatocyte-like cells derived from induced pluripotent stem cells.

Authors:  Namita Roy-Chowdhury; Xia Wang; Chandan Guha; Jayanta Roy-Chowdhury
Journal:  Hepatol Int       Date:  2016-08-17       Impact factor: 6.047

3.  Chromosomal integration of adenoviral vector DNA in vivo.

Authors:  Sam Laurel Stephen; Eugenio Montini; Vijayshankar Ganesh Sivanandam; Muhseen Al-Dhalimy; Hans A Kestler; Milton Finegold; Markus Grompe; Stefan Kochanek
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

4.  Genomic integration of adenoviral gene transfer vectors following transduction of fertilized mouse oocytes.

Authors:  Nancy Larochelle; Rolf Stucka; Norman Rieger; Lothar Schermelleh; Gudrun Schiedner; Stefan Kochanek; Eckhard Wolf; Hanns Lochmüller
Journal:  Transgenic Res       Date:  2010-05-13       Impact factor: 2.788

5.  Induced pluripotent stem cells as a source of hepatocytes.

Authors:  Vanessa Sauer; Namita Roy-Chowdhury; Chandan Guha; Jayanta Roy-Chowdhury
Journal:  Curr Pathobiol Rep       Date:  2014-03

6.  Hyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B.

Authors:  Martin A Hausl; Wenli Zhang; Nadine Müther; Christina Rauschhuber; Helen G Franck; Elizabeth P Merricks; Timothy C Nichols; Mark A Kay; Anja Ehrhardt
Journal:  Mol Ther       Date:  2010-08-17       Impact factor: 11.454

Review 7.  Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.

Authors:  Robert D Wyse; Gary L Dunbar; Julien Rossignol
Journal:  Int J Mol Sci       Date:  2014-01-23       Impact factor: 5.923

8.  A Novel Adenoviral Hybrid-vector System Carrying a Plasmid Replicon for Safe and Efficient Cell and Gene Therapeutic Applications.

Authors:  Richard Voigtlander; Rudolf Haase; Martin Mück-Hausl; Wenli Zhang; Philip Boehme; Hans-Joachim Lipps; Eric Schulz; Armin Baiker; Anja Ehrhardt
Journal:  Mol Ther Nucleic Acids       Date:  2013-04-02       Impact factor: 10.183

9.  Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease.

Authors:  Sam L Stephen; Katie Freestone; Sarah Dunn; Michael W Twigg; Shervanthi Homer-Vanniasinkam; John H Walker; Stephen B Wheatcroft; Sreenivasan Ponnambalam
Journal:  Int J Hypertens       Date:  2010-08-17       Impact factor: 2.420

Review 10.  Potential of Induced Pluripotent Stem Cells for Use in Gene Therapy: History, Molecular Bases, and Medical Perspectives.

Authors:  Agnieszka Fus-Kujawa; Barbara Mendrek; Anna Trybus; Karolina Bajdak-Rusinek; Karolina L Stepien; Aleksander L Sieron
Journal:  Biomolecules       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.